Blood Pressure Medication Recall Raises Concerns for Communities Already Disproportionately Affected by Hypertension
The FDA has recalled specific lots of chlorthalidone tablets after quality testing found the medication may not dissolve properly, potentially reducing its effectiveness in controlling high blood pressure. Here’s what patients—especially those in communities disproportionately affected by hypertension—need to know, how to check if their medication is affected, and what steps to take next.



















